Staying Informed

Alimera Sciences Receives Complete Response Letter For ILUVIEN®

ATLANTA, Oct. 18, 2013 /PRNewswire/ -- Alimera Sciences, Inc., (NASDAQ: ALIM) (Alimera), a biopharmaceutical company that specializes in the research, development and commercialization of prescription ...
 
Business For Sale in Atlanta News Snippet brought to you by: BizLocal.com
BizLocal provides a Business For Sale Market Place and more. 
A web-property of Inspetta LLC, providing innovative web, software and marketing services to business.  
Call 800-785-2925 for more information.
Comments
Only registered users can leave comments.
Comment text: